Literature DB >> 6239877

Familial protein S deficiency is associated with recurrent thrombosis.

P C Comp, R R Nixon, M R Cooper, C T Esmon.   

Abstract

Recent studies have demonstrated that protein C deficiency is associated with recurrent familial thrombosis. In plasma, activated protein C functions as an anticoagulant. This anticoagulant response requires a vitamin K-dependent plasma protein cofactor, referred to as protein S. Since the anticoagulant activity of activated protein C is dependent on protein S, we hypothesized that patients lacking functional protein S might have associated thrombotic disease. Two related individuals with otherwise normal coagulation tests are described whose plasma is not effectively anticoagulated with activated protein C. Addition of purified human protein S to their plasma restores a normal anticoagulant response to activated protein C. We have developed a rapid one-stage clotting assay for protein S to quantitate the level of protein S in their plasma. Plasma is depleted of protein S by immunoadsorption with immobilized antiprotein S antibodies. The resultant plasma responds poorly to activated protein C, but is effectively anticoagulated in a dose-dependent fashion upon addition of purified protein S or small quantities of plasma. The affected individuals possess less than 5% protein S activity. Using Laurell rockets, protein S antigen was detected in the plasma but was at reduced levels of 13 and 18% in the two individuals. When the barium eluate of the patient plasma was chromatographed on quaternary aminoethyl Sephadex, a single peak of protein S antigen devoid of protein S anticoagulant cofactor activity was detected early in the chromatogram. In contrast, the barium eluate from normal donors separated into two peaks, one emerging early and also devoid of anticoagulant cofactor, and the second peak with anticoagulant activity emerging later. The first peak of protein S antigen, from both the normal donor and the patient, chromatographed in the region of the complement component C4-binding protein-protein S complex. These studies suggest that protein S deficiency may result in recurrent thrombotic disease.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6239877      PMCID: PMC425398          DOI: 10.1172/JCI111632

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  19 in total

1.  The subunit structure of thrombin-activated factor V. Isolation of activated factor V, separation of subunits, and reconstitution of biological activity.

Authors:  C T Esmon
Journal:  J Biol Chem       Date:  1979-02-10       Impact factor: 5.157

2.  Abnormal plasminogen. A hereditary molecular abnormality found in a patient with recurrent thrombosis.

Authors:  N Aoki; M Moroi; Y Sakata; N Yoshida; M Matsuda
Journal:  J Clin Invest       Date:  1978-05       Impact factor: 14.808

3.  Purification of an apparent rat liver prothrombin precursor: characterization and comparison to normal rat prothrombin.

Authors:  C T Esmon; G A Grant; J W Suttie
Journal:  Biochemistry       Date:  1975-04-22       Impact factor: 3.162

4.  A comparison of human prothrombin, factor IX (Christmas factor), factor X (Stuart factor), and protein S.

Authors:  R G Di Scipio; M A Hermodson; S G Yates; E W Davie
Journal:  Biochemistry       Date:  1977-02-22       Impact factor: 3.162

5.  Purification of human vitamin K-dependent protein S and its limited proteolysis by thrombin.

Authors:  B Dahlbäck
Journal:  Biochem J       Date:  1983-03-01       Impact factor: 3.857

6.  Regulation of activated protein C by protein S. The role of phospholipid in factor Va inactivation.

Authors:  F J Walker
Journal:  J Biol Chem       Date:  1981-11-10       Impact factor: 5.157

7.  High molecular weight complex in human plasma between vitamin K-dependent protein S and complement component C4b-binding protein.

Authors:  B Dahlbäck; J Stenflo
Journal:  Proc Natl Acad Sci U S A       Date:  1981-04       Impact factor: 11.205

8.  Deficiency of protein C in congenital thrombotic disease.

Authors:  J H Griffin; B Evatt; T S Zimmerman; A J Kleiss; C Wideman
Journal:  J Clin Invest       Date:  1981-11       Impact factor: 14.808

9.  Regulation of activated protein C by a new protein. A possible function for bovine protein S.

Authors:  F J Walker
Journal:  J Biol Chem       Date:  1980-06-25       Impact factor: 5.157

10.  Protein C deficiency in a Dutch family with thrombotic disease.

Authors:  R M Bertina; A W Broekmans; I K van der Linden; K Mertens
Journal:  Thromb Haemost       Date:  1982-08-24       Impact factor: 5.249

View more
  67 in total

1.  Chemical synthesis and spontaneous folding of a multidomain protein: anticoagulant microprotein S.

Authors:  T M Hackeng; J A Fernández; P E Dawson; S B Kent; J H Griffin
Journal:  Proc Natl Acad Sci U S A       Date:  2000-12-19       Impact factor: 11.205

2.  Endogenous thrombin potential changes during the first cycle of oral contraceptive use.

Authors:  Carolyn L Westhoff; Malcolm C Pike; Serge Cremers; Andrew Eisenberger; Stella Thomassen; Jan Rosing
Journal:  Contraception       Date:  2017-01-11       Impact factor: 3.375

Review 3.  C4b-binding protein, a regulatory protein of complement.

Authors:  S R Barnum
Journal:  Immunol Res       Date:  1991       Impact factor: 2.829

4.  Internal medicine: the protein C anticoagulant pathway and thrombosis.

Authors:  R B Francis
Journal:  West J Med       Date:  1985-07

5.  Cloning of cDNA coding for the beta chain of human complement component C4b-binding protein: sequence homology with the alpha chain.

Authors:  A Hillarp; B Dahlbäck
Journal:  Proc Natl Acad Sci U S A       Date:  1990-02       Impact factor: 11.205

6.  The Journey of Protein S from an Anticoagulant to a Signaling Molecule.

Authors:  V S Pilli; William Plautz; Rinku Majumder
Journal:  JSM Biochem Mol Biol       Date:  2016-08-08

7.  [Significance of the endothelium of the vascular wall for maintaining hemostasis].

Authors:  U Delvos; G Müller-Berghaus
Journal:  Klin Wochenschr       Date:  1985-12-16

Review 8.  Current issues in thrombosis prevention with antiplatelet drugs.

Authors:  G de Gaetano; C Cerletti; E Dejana; J Vermylen
Journal:  Drugs       Date:  1986-06       Impact factor: 9.546

9.  LPS-Toll-Like Receptor-Mediated Signaling on Expression of Protein S and C4b-Binding Protein in the Liver.

Authors:  Tatsuya Hayashi; Koji Suzuki
Journal:  Gastroenterol Res Pract       Date:  2010-08-18       Impact factor: 2.260

10.  [Intracranial and intraspinal hemorrhages in treatment with coumarin derivatives. Catamnesis of 63 cases between 1978 and 1986].

Authors:  D Moskopp; F Brassel; F Ries
Journal:  Klin Wochenschr       Date:  1987-08-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.